Clinical Trials

Inclusion Criteria:

• Patients from 18 to 80 years of age.
• Patients at risk of NAFLD-NASH referred to hepatology specialists by their referring physician for further investigation, with or without a liver biopsy.
• Patients screened for fibrotic NASH in the context of NASH pharmaceutical trials.
• Patients who consent in written to participate in the Clinical Investigation after being orally informed on the objectives and methods of the Clinical Investigation.

Exclusion Criteria:

• Patients under 18 years of age or over 80 years of age.
• Patients with active implants such as pacemakers, defibrillators, pumps, etc.
• Patients presenting wounds at the location where the Hepatoscope probe shall be placed on patients’ skin.
• Adult patients under social tutorship, or unable to provide informed consent when not subject to tutorship measures.
• Pregnant and breastfeeding women.
• People deprived of their freedom rights.
• People who have been hospitalized without giving informed consent or under emergency situation.
• People admitted in a social or sanitary institution for other reasons than the Clinical Investigation.
• Patients included in another research study that could interfere with the present Clinical Investigation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/20/23. Questions regarding updates should be directed to the study team contact.